ERS clinical practice guidelines for managing children and adolescents with bronchiectasis

This ERS Congress 2021 guidelines session describes the objectives of managing children/adolescents with bronchiectasis; presents the ERS recommendations relating to diagnosing and undertaking the minimum investigations when evaluating a child/adolescent with chronic suppurative lung disease; explains reasons for the various recommendations; and increases awareness of the guideline’s recommendations on antibiotic treatment of exacerbations, pathogen eradication, long-term antibiotic therapy, asthma-type therapies (inhaled corticosteroids, bronchodilators), mucoactive drugs, airway clearance, disease monitoring, factors to consider before surgical treatment and the reversibility and prevention of bronchiectasis in children/adolescents.

You can still register for the ERS International Congress and have access to ALL sessions from the event until the end of December.

ERS Congress 2021

Relive the ERS Congress 2021

ERS International Congress 2021 delegates can access all content and session recordings at any time until the end of December 2021. If you did not take part, you can still register to access this content.

Access the platform / register